Women in the UK, and elsewhere, are still missing out on vital treatment for their No 1 killer – cardiovascular disease – despite significant progress in the medical management of heart disease and stroke, concludes a consensus statement published online in the journal Heart.
They continue to be underdiagnosed, undertreated, and underrepresented in clinical trials in all areas of cardiovascular disease, says the statement.
Women in the UK, and elsewhere, are still missing out on vital treatment for their No 1 killer – cardiovascular disease – despite significant progress in the medical management of heart disease and stroke, concludes a consensus statement published online in the journal Heart.
They continue to be underdiagnosed, undertreated, and underrepresented in clinical trials in all areas of cardiovascular disease, says the statement.
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
